McAdam LLC Portfolio holdings
Top Buys
| 1 |
Schwab US Large- Cap ETF
SCHX
|
+$14.5M |
| 2 |
Schwab International Equity ETF
SCHF
|
+$11.8M |
| 3 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$11.6M |
| 4 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$11.3M |
| 5 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$7.68M |
Top Sells
Sector Composition
| 1 | Technology | 1.57% |
| 2 | Healthcare | 1.09% |
| 3 | Consumer Discretionary | 0.76% |
| 4 | Financials | 0.65% |
| 5 | Communication Services | 0.63% |
Similar funds
McAdam LLC's Q2 2021 Portfolio in Review
As of Q2 2021, McAdam LLC held 180 positions worth $881M, up 24% from $709M the previous quarter. Its ten largest holdings account for 62% of the portfolio.
McAdam LLC deployed $118M of net new capital in Q2 2021, opening 19 new positions and adding to 101 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 3,345 shares worth $1.95M.
By sector, the portfolio is most concentrated in Technology at 1.6% of assets, up from 1.3% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 400 Mid Cap Growth ETF, an estimated $616K trimmed.
- McAdam LLC's largest Q2 2021 buy was Regeneron Pharmaceuticals: 3,345 shares worth $1.95M.
- McAdam LLC added most to Schwab US Large- Cap ETF in Q2 2021, an estimated $14.5M increase.
- McAdam LLC's biggest Q2 2021 reduction was State Street SPDR S&P 400 Mid Cap Growth ETF, cutting an estimated $616K.
- McAdam LLC fully exited FS KKR Capital Corp. II in Q2 2021, selling an estimated $565K.
- McAdam LLC's ten largest holdings make up 62% of its $881M portfolio in Q2 2021.
- McAdam LLC opened 19 new positions and closed 3 in Q2 2021.
- McAdam LLC's portfolio value rose 24% quarter-over-quarter to $881M.
Based on McAdam LLC's 13F filing for Q2 2021, filed 2 Aug 2021.